touching the endothelium in the right eye and a well-positioned posterior chamber IOL in the left eye. This case describes a rare presentation of unilateral secondary amyloidosis with lattice-like ...

CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.

The eyes can reveal much more than just vision ... may be one of the earliest signs of Alzheimer’s disease. The toxic amyloid plaques associated with the disease can first affect parts of ...

Dry eyes after LASIK may be caused by your eyes not producing enough moisturizing tears while they heal. Artificial lubricants can alleviate these symptoms, which typically resolve in a few months.

Combining the imaging techniques significantly improved the accuracy of diagnosis. The study team set out to test how effective combining 11 C-PiB PET/CT and 99m Tc-DPD scintigraphy would be in ...

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...

Vutrisiran improved all-cause mortality and recurrent CV independent of disease severity in cardiac amyloidosis. Regardless of cutoffs, vutrisiran also improved various health and quality of life ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

Vutrisiran is already approved as Amvuttra to treat rare disease hereditary ATTR amyloidosis ... before the end of this year in the genetic eye disease, which causes fatty material to build ...

The other authors report no conflicts. Dr Vanhentenrijk is supported by a grant from the Belgian American Educational Foundation and the Pfizer transthyretin amyloidosis fellowship grant. Drs Grodin ...

Phase 3 – REVEAL study with 124 I-evuzamitide in patients with suspected cardiac amyloidosis is ongoing by Brigham and Women’s Hospital, Boston, MA. AT-05 (99mTc-p5+14), a radiotracer, designed for ...